Methyl 4-((1-Methylpiperidin-4-yl)Methoxy)-3-Methoxybenzoate
![]() |
- $261 - $606
- Product name: Methyl 4-((1-Methylpiperidin-4-yl)Methoxy)-3-Methoxybenzoate
- CAS: 635678-09-0
- MF: C16H23NO4
- MW: 293.36
- EINECS:
- MDL Number:MFCD18157679
- Synonyms:Methyl 4-((1-Methylpiperidin-4-yl)Methoxy)-3-Methoxybenzoate;Benzoic acid, 3-methoxy-4-[(1-methyl-4-piperidinyl)methoxy]-, methyl ester
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number7163AE
- Product descriptionMethyl3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate
- Packaging1g
- Price$491
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11082803
- Product descriptionMethyl3-methoxy-4-((1-methylpiperidin-4-yl)methoxy)benzoate 95+%
- Packaging5g
- Price$606
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number058673
- Product descriptionMethyl 3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate >95%
- Packaging500mg
- Price$261
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number058673
- Product descriptionMethyl 3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate >95%
- Packaging1g
- Price$327
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7163AE | Methyl3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate | 1g | $491 | 2021-12-16 | Buy |
Crysdot | CD11082803 | Methyl3-methoxy-4-((1-methylpiperidin-4-yl)methoxy)benzoate 95+% | 5g | $606 | 2021-12-16 | Buy |
Matrix Scientific | 058673 | Methyl 3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate >95% | 500mg | $261 | 2021-12-16 | Buy |
Matrix Scientific | 058673 | Methyl 3-methoxy-4-[(1-methylpiperidin-4-yl)-methoxy]benzoate >95% | 1g | $327 | 2021-12-16 | Buy |
Properties
Melting point :83~85℃
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|